We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
-0.83%
1 Year Est. Return
+18.41%
3 Year Est. Return
+59.5%
5 Year Est. Return
+69.09%
10 Year Est. Return
AUM
$10.9B
AUM Growth
+$3.01B
Cap. Flow
+$3.35B
Cap. Flow %
30.64%
Top 10 Hldgs %
32.26%
Holding
2,911
New
179
Increased
662
Reduced
956
Closed
673

Sector Composition

Rank Sector Weight
1 Technology 9.57%
2 Industrials 9.07%
3 Financials 5.38%
4 Consumer Discretionary 4.16%
5 Healthcare 3.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBIX icon
851
Neurocrine Biosciences
NBIX
$17.5B
$306K ﹤0.01%
2,319
-766
-25% -$102K
DFAC icon
852
Dimensional US Core Equity 2 ETF
DFAC
$47.4B
$305K ﹤0.01%
7,857
AEIS icon
853
Advanced Energy
AEIS
$12.6B
$305K ﹤0.01%
945
+908
+2,454% +$263K
TTC icon
854
Toro Company
TTC
$8.72B
$304K ﹤0.01%
3,255
-116
-3% -$10.9K
PKG icon
855
Packaging Corp of America
PKG
$20.8B
$304K ﹤0.01%
1,433
-219
-13% -$48.8K
TD icon
856
Toronto Dominion Bank
TD
$197B
$304K ﹤0.01%
3,254
IYF icon
857
iShares US Financials ETF
IYF
$4.35B
$304K ﹤0.01%
2,580
+580
+29% +$72K
RYLD icon
858
Global X Russell 2000 Covered Call ETF
RYLD
$1.36B
$303K ﹤0.01%
20,282
SCHZ icon
859
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$301K ﹤0.01%
12,967
+105
+0.8% +$2.46K
WU icon
860
Western Union
WU
$2.6B
$301K ﹤0.01%
34,487
EWY icon
861
iShares MSCI South Korea ETF
EWY
$23.2B
$301K ﹤0.01%
+2,446
New +$306K
ANRO icon
862
Alto Neuroscience
ANRO
$1.04B
$299K ﹤0.01%
+13,312
New +$247K
DFEM icon
863
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
$8.93B
$298K ﹤0.01%
8,626
-694
-7% -$24.6K
DKNG icon
864
DraftKings
DKNG
$11.3B
$298K ﹤0.01%
13,775
+423
+3% +$11.5K
ENS icon
865
EnerSys
ENS
$7.29B
$297K ﹤0.01%
1,712
+898
+110% +$152K
SGOL icon
866
abrdn Physical Gold Shares ETF
SGOL
$6.91B
$297K ﹤0.01%
6,655
FVD icon
867
First Trust Value Line Dividend Fund
FVD
$8.19B
$297K ﹤0.01%
6,311
+5
+0.1% +$240
PSMT icon
868
Pricesmart
PSMT
$5.76B
$295K ﹤0.01%
1,963
-519
-21% -$75.8K
DOCT
869
FT Vest US Equity Deep Buffer ETF October
DOCT
$382M
$294K ﹤0.01%
6,764
DNOV icon
870
FT Vest US Equity Deep Buffer ETF November
DNOV
$394M
$293K ﹤0.01%
6,124
FBIN icon
871
Fortune Brands Innovations
FBIN
$5.94B
$292K ﹤0.01%
7,505
-5,868
-44% -$305K
MDB icon
872
MongoDB
MDB
$24.1B
$292K ﹤0.01%
1,192
+366
+44% +$122K
OCSL icon
873
Oaktree Specialty Lending
OCSL
$1.02B
$292K ﹤0.01%
25,797
+9,296
+56% +$111K
ET icon
874
Energy Transfer Partners
ET
$70.3B
$291K ﹤0.01%
15,079
+50
+0.3% +$916
VOOG icon
875
Vanguard S&P 500 Growth ETF
VOOG
$25.5B
$290K ﹤0.01%
4,272
+30
+0.7% +$2.17K

Similar funds

Clearstead Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Clearstead Advisors held 2,911 positions worth $10.9B, up 38% from $7.93B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Clearstead Advisors deployed $3.35B of net new capital in Q1 2026, opening 179 new positions and adding to 662 existing holdings. Its largest new stake was Dimensional International High Profitability ETF: 5,528,400 shares worth $178M.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, down from 12% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was iShares MSCI USA Quality Factor ETF, an estimated $37.5M trimmed.

  • Clearstead Advisors's largest Q1 2026 buy was Dimensional International High Profitability ETF: 5,528,400 shares worth $178M.
  • Clearstead Advisors added most to PACCAR in Q1 2026, an estimated $588M increase.
  • Clearstead Advisors's biggest Q1 2026 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $37.5M.
  • Clearstead Advisors fully exited Vanguard S&P 500 ETF in Q1 2026, selling an estimated $732M.
  • Clearstead Advisors's ten largest holdings make up 32% of its $10.9B portfolio in Q1 2026.
  • Clearstead Advisors opened 179 new positions and closed 673 in Q1 2026.
  • Clearstead Advisors's portfolio value rose 38% quarter-over-quarter to $10.9B.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.